Works matching IS 25233548 AND DT 2024 AND VI 44 AND IP 8

Results: 9

Boron neutron capture therapy of cancer: where do we stand now?

Published in:

Cancer Communications, 2024, v. 44, n. 8, p. 889, doi. 10.1002/cac2.12581

By:

Barth, Rolf F.;
Wu, Gong;
Vicente, Maria da Graca H.;
Grecula, John C;
Gupta, Nilendu

Publication type:

Article

SALIRI‐based (raltitrexed plus irinotecan) therapy as a second‐line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non‐interventional, registry study.

Published in:

Cancer Communications, 2024, v. 44, n. 8, p. 910, doi. 10.1002/cac2.12586

By:

Qin, Shuqui;
Li, Jin;
Zhou, Aiping;
Zhang, Yanqiao;
Yuan, Xianglin;
Zhu, Liangjun;
Qin, Baoli;
Zeng, Shan;
Shen, Lin;
Yuan, Ying;
Wang, Weibo;
Liang, Jun;
Zhang, Xianwen;
Ye, Feng;
Chen, Ping;
Wang, Huaizhang;
Yu, Zhenyan;
Yue, Lu;
Fang, Yong;
Xiong, Jianping

Publication type:

Article

Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma.

Published in:

Cancer Communications, 2024, v. 44, n. 8, p. 921, doi. 10.1002/cac2.12585

By:

Hyun, Sangyeop;
Han, Youngmin;
Moon, Jae Yun;
Suh, Young‐Ah;
Yun, Won‐Gun;
Kwon, Wooil;
Lee, Jong‐Eun;
Kim, Daeun;
Ku, Ja‐Lok;
Jang, Jin‐Young;
Park, Daechan

Publication type:

Article

Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer.

Published in:

Cancer Communications, 2024, v. 44, n. 8, p. 855, doi. 10.1002/cac2.12583

By:

Xiao, Jian;
Cao, Shuqing;
Wang, Jiawei;
Li, Pengyu;
Cheng, Quan;
Zhou, Xinyi;
Dong, Jiacheng;
Li, Yuan;
Zhao, Xinyu;
Xu, Zekuan;
Yang, Li

Publication type:

Article

Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT.

Published in:

Cancer Communications, 2024, v. 44, n. 8, p. 893, doi. 10.1002/cac2.12582

By:

Barth, Rolf F.;
Gupta, Nilendu;
Kawabata, Shinji

Publication type:

Article

Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy.

Published in:

Cancer Communications, 2024, v. 44, n. 8, p. 915, doi. 10.1002/cac2.12590

By:

Schnekenburger, Michael;
Lorant, Anne;
Gajulapalli, Sruthi Reddy;
Rajora, Ridhika;
Lee, Jin‐Young;
Mazumder, Aloran;
Yang, Haeun;
Christov, Christo;
Kang, Hyoung Jin;
Pirotte, Bernard;
Diederich, Marc

Publication type:

Article

Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity.

Published in:

Cancer Communications, 2024, v. 44, n. 8, p. 884, doi. 10.1002/cac2.12589

By:

Choi, Sung Hee;
Myers, Jay Thomas;
Tomchuck, Suzanne Louise;
Bonner, Melissa;
Eid, Saada;
Kingsley, Daniel Tyler;
VanHeyst, Kristen Ashley;
Kim, Seong‐Jin;
Kim, Byung‐Gyu;
Huang, Alex Yee‐Chen

Publication type:

Article

Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis.

Published in:

Cancer Communications, 2024, v. 44, n. 8, p. 879, doi. 10.1002/cac2.12588

By:

Chander, Anjali;
Iacovacci, Jacopo;
Pellon, Aize;
Kataria, Rhadika;
Grigoriadis, Anita;
Maher, John;
Sears, Cynthia;
Bachrach, Gilad;
Urbano, Teresa Guerrero;
Lei, Mary;
Petkar, Imran;
Kong, Anthony;
Ng, Tony;
Orlandi, Ester;
Iacovelli, Nicola Alessandro;
De Cecco, Loris;
Serafini, Mara Serena;
Moyes, David;
Rancati, Tiziana;
Ferreira, Miguel Reis

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2024, v. 44, n. 8, p. 853, doi. 10.1002/cac2.12437
Publication type:: Article